Two-Year Clinical Outcomes of Critical Limb-Threatening Ischemia Versus Claudication After Femoropopliteal Endovascular Therapy: An Analysis from K-VIS ELLA Registry

作者
Soohyung Park,Markz R. M. P. Sinurat,Seung‐Woon Rha,Byoung Geol Choi,Jah Yeon Choi,CHEOL UNG CHOI,Young‐Guk Ko,Donghoon Choi,Jae-Hwan Lee,Chang‐Hwan Yoon,In‐Ho Chae,Cheol Woong Yu,Seung‐Whan Lee,Seung‐Hyuk Choi,Pil‐Ki Min,Chang Gyu Park,on behalf of the K-VIS (Korean Vascular Intervention Society) Investigators
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:14 (24): 8919-8919
标识
DOI:10.3390/jcm14248919
摘要

Background/Objectives: Endovascular therapy (EVT) is the treatment of choice for femoropopliteal artery (FPA) disease manifesting as critical limb-threatening ischemia (CLTI) or intermittent claudication (IC). This study aimed to compare the clinical outcomes of patients with CLTI with those of patients with IC after EVT in a real-world setting. Methods: In total, 1924 patients with FPA disease (CLTI: n = 812, IC: n = 1112) from the K-VIS ELLA (Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases) registry who underwent EVT between 2006 and 2021 were analyzed. The primary endpoint was defined as target limb amputation or clinically driven (CD) target extremity revascularization (TER) 2 years after the procedure. Results: The incidence of the primary endpoint after inverse probability of treatment weighting (IPTW) was significantly higher in the CLTI group (hazard ratio [HR], 1.314; 95% confidence interval [CI], 1.105–1.561; p = 0.002). The incidences of loss of clinical patency, major adverse limb events (MALEs), and all-cause mortality were also higher in the CLTI group (hazard ratio [HR], 1.312; 95% confidence interval [CI], 1.157–1.488; p < 0.001). However, the risk of repeat percutaneous transluminal angioplasty (PTA) was similar between the groups (HR, 1.014; 95% CI, 0.833–1.234; p = 0.920). The use of drug-coated balloons (DCBs) was associated with favorable primary outcomes in both groups, particularly in patients with IC (HR: 0.429, 95% CI: 0.25–0.734; p = 0.002). Conclusions: Patients with CLTI undergoing EVT for FPA disease experienced worse clinical outcomes than those with IC, although the repeat PTA rates were similar. The use of DCBs showed promising results in both groups.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
奶花泡芙完成签到,获得积分10
刚刚
宇宙里的小海洋完成签到,获得积分10
刚刚
淡然冰之完成签到,获得积分10
1秒前
JamesPei的应助被jovisong采纳,获得10
1秒前
YC完成签到,获得积分10
1秒前
2秒前
小超超超腻害完成签到 ,获得积分10
3秒前
3秒前
3秒前
3秒前
4秒前
无花果的应助被Dana采纳,获得10
4秒前
4秒前
hhud发布了新的文献求助10
4秒前
Hello的应助被anzer采纳,获得10
5秒前
5秒前
Dylan完成签到,获得积分10
5秒前
易怀亮完成签到,获得积分10
6秒前
大个的应助被曾女士采纳,获得10
6秒前
英勇羿发布了新的文献求助10
6秒前
6秒前
领导范儿的应助被QQ采纳,获得10
7秒前
GUI完成签到,获得积分10
7秒前
7秒前
Savanna完成签到,获得积分10
8秒前
8秒前
小衫生完成签到,获得积分10
8秒前
Hello的应助被笨笨的紫槐采纳,获得10
8秒前
培安完成签到,获得积分10
9秒前
liusong发布了新的文献求助10
9秒前
星辰大海的应助被风韵犹存采纳,获得10
9秒前
10秒前
cdercder的应助被云隐采纳,获得10
10秒前
迷人乐珍完成签到,获得积分20
10秒前
xvan发布了新的文献求助30
11秒前
帅气采枫完成签到,获得积分10
11秒前
jiyu完成签到,获得积分10
11秒前
Orange的应助被秋夕未见君采纳,获得10
11秒前
闪闪冬天发布了新的文献求助10
11秒前
小丁崽发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153389
求助须知:如何正确求助?哪些是违规求助? 9550014
关于积分的说明 21696271
捐赠科研通 7741851
什么是DOI,文献DOI怎么找? 3425440
关于科研通互助平台的介绍 2550608
邀请新用户注册赠送积分活动 2469123